Terms: = Testicular cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
7 results:
1. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
[TBL] [Abstract] [Full Text] [Related]
2. Protective mechanisms of resveratrol against methotrexate-induced renal damage may involve bcrp/abcg2.
El-Sheikh AA; Morsy MA; Al-Taher AY
Fundam Clin Pharmacol; 2016 Oct; 30(5):406-18. PubMed ID: 27213989
[TBL] [Abstract] [Full Text] [Related]
3. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.
Hoque MT; Kis O; De Rosa MF; Bendayan R
Antimicrob Agents Chemother; 2015 May; 59(5):2572-82. PubMed ID: 25691630
[TBL] [Abstract] [Full Text] [Related]
4. Histological groups of human postpubertal testicular germ cell tumours harbour different genetic alterations.
Vladušić T; Hrašćan R; Krušlin B; Pećina-Šlaus N; Perica K; Bićanić A; Vrhovac I; Gamulin M; Franekić J
Anticancer Res; 2014 Aug; 34(8):4005-12. PubMed ID: 25075023
[TBL] [Abstract] [Full Text] [Related]
5. Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro.
Dankers AC; Roelofs MJ; Piersma AH; Sweep FC; Russel FG; van den Berg M; van Duursen MB; Masereeuw R
Toxicol Sci; 2013 Dec; 136(2):382-91. PubMed ID: 24014645
[TBL] [Abstract] [Full Text] [Related]
6. The distribution of drug-efflux pumps, P-gp, bcrp, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours.
Bart J; Hollema H; Groen HJ; de Vries EG; Hendrikse NH; Sleijfer DT; Wegman TD; Vaalburg W; van der Graaf WT
Eur J Cancer; 2004 Sep; 40(14):2064-70. PubMed ID: 15341980
[TBL] [Abstract] [Full Text] [Related]
7. Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.
Zurita AJ; Diestra JE; Condom E; García Del Muro X; Scheffer GL; Scheper RJ; Pérez J; Germà-Lluch JR; Izquierdo MA
Br J Cancer; 2003 Mar; 88(6):879-86. PubMed ID: 12644825
[TBL] [Abstract] [Full Text] [Related]
